kettering Archives - Good News!

Hong Kong Dragon Boat Festival August 3rd, 2024 Flushing Meadow, NY

Austin Tang — Tue, 20 Aug 2024 16:57:26 +0000

Listen to “Hong Kong Dragon Boat Festival August 3, 2024 Welcome” on Spreaker.

AARP SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL

Listen to “AARP SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL” on Spreaker.

NORTHWELL HEALTH CARE SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL

Listen to “NORTHWELL HEALTH CARE SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL” on Spreaker.

Memorial Sloan Kettering .SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL

Listen to “Memorial Sloan Kettering .SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL” on Spreaker.

VERIZON SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL

Listen to “VERIZON SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL” on Spreaker.

IAN THE FESTIVAL Announcer for 20 years and Emily Post SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL

Listen to “IAN THE FESTIVAL Announcer for 20 years and Emily Post SHARES THEIR GOOD NEWS AT THE HONG KONG DRAGON BOAT FESTIVAL” on Spreaker.

HENRY WAN Founder of the Hong Kong Dragon BOAT FESTIVAL and Racers Close the Good News Broadcast

Listen to “HENRY WAN Founder of the Hong Kong Dragon BOAT FESTIVAL and Racers Close the Good News Broadcast” on Spreaker.

#hongkongdragonboatfestival

The post Hong Kong Dragon Boat Festival August 3rd, 2024 Flushing Meadow, NY appeared first on Good News!.

A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.

Austin Tang — Wed, 04 Mar 2020 18:55:41 +0000

http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.mp3
There are a variety of reasons why treatments fail, and patients need to work with their healthcare team to explore their options if treatment failure occurs.
Herewith tips for patients, are Dr. Michael Mauro, (More-oh) and Karen, who is living with chronic myeloid leukemia, or CML.
BIO:DR. MICHAEL MAURO:
• Michael Mauro, MD, Professor of Medicine, Member and Attending Physician and Leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
o Dr. Mauro’s clinical expertise is in treating patients with chronic myeloid leukemia (CML), as well as other myeloproliferative disorders, including myelofibrosis, polycythemia and thrombocytosis. In practice, he offers in-depth explanation regarding diagnoses and therapy options, and is a proponent of active partnerships with his patients to personalize decision-making and monitoring. He is a board-certified hematologist and leader of the Myeloproliferative Neoplasms Program within the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSKCC). Before joining Memorial Sloan Kettering, Dr. Mauro was on the faculty of Oregon Health and Sciences University for 13 years. There, he directed the CML clinical trial program. He completed both residency and fellowship training at New York-Presbyterian Hospital / Weill Cornell Medical College in New York City.
o Location: Practices in both Manhattan (NYC) and Montvale, NJ campuses of MSKCC
o Specialty/Areas of Focus: Chronic Myeloid Leukemia; Myelofibrosis; Polycythemia; Thrombocytosis, Other Myeloproliferative Disorders
o Education: MD, Dartmouth Medical School
o Board Certifications: Hematology
BIO:KAREN L.
o Bio: Karen is a teacher, former runner turned yogi, wife and mother of two from Eden Prairie, Minnesota.
o Journey with CML:
§ When she began losing excessive weight and noticed a weakness in her legs during runs, she initially attributed these symptoms to turning 40 years old. Eventually she decided to visit her doctor, but her doctor was not concerned and told her to come back in a few months if she was still experiencing the same symptoms.
§ A few months later, Karen returned to her doctor for an ultrasound, which revealed her spleen was enlarged. Following a blood test, a nurse called Karen and told her it was suspected she had blood cancer and urged Karen to come straight to the hospital. The nurse expressed concerns about her potentially being at risk for a stroke. After further testing, it was confirmed that Karen had chronic myeloid leukemia (CML). Karen spent several days in the hospital to help regulate the CML. After she was released from the hospital, Karen started taking a daily medication to help control the CML. Eventually Karen was able to return to teaching and her usual activities.
§ Following her initial diagnosis, Karen developed a genetic mutation that caused her treatment for CML to stop working. Since there were no available treatment options effective against the mutation, Karen enrolled in a clinical trial and responded well to the treatment she was given.
§ Today,Karen remains on the medication she took in the clinical trial and is stillteaching.
#leukemia #diagnosis #treatment #plan #patients #need #michael #mauro #cml #chronic #myeloid #karen #medicine #physician #myeloproliferative #neoplasms #program #memorial #sloan #kettering #cancer #center #new #york #ny #teacher #yoga #education

The post A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next. appeared first on Good News!.

Peter Fleiss – Corporate Angel Network’s Executive Director Emeritus

admin — Tue, 03 May 2016 17:38:18 +0000

One-Year-Old with Rare Cancer Flies to NYC for Treatment Free

on 50,000th Corporate Angel Network Patient Flight. Good News speaks to Peter Fleiss – Corporate Angel Network’s Executive Director Emeritus

On the evening of April 14, 2016, one-year-old cancer patient Baron Yerby will fly home to Atlanta after a treatment at Memorial Sloan Kettering. However, this flight will be quite different than the others he’s taken after treatment. Instead of flying on a crowded commercial plane with the potential for immune deficiency issues, he and his parents will fly in comfort, free of charge, on a corporate jet, belonging to NCR, a Fortune 500 Company headquartered in Atlanta. The flight was arranged by Corporate Angel Network, (www.corpangelnetwork.org ) the only charitable organization in the United States whose sole mission is to help cancer patients access the best possible treatment for their specific type of cancer by arranging free travel in the empty seats of corporate jets. It’s also their 50,000th patient flight.

When Baron was three months old, his parents, Jonathan, a college professor, and Casey, a social worker, became concerned about an odd glow in his right eye. He was soon diagnosed with retinoblastoma, a rare form of eye cancer. The tumor in his right eye was huge and there were smaller tumors in the left eye. After receiving chemo in Atlanta, all seemed to be going well, but 30 new tumors suddenly appeared in Baron’s left eye. The family was told that all treatment options had been exhausted – except for one that was performed only at Memorial Sloan Kettering in NYC. The procedure directs a high dose of chemo right to the eye tumor by going up through Baron’s groin and prevents the effects of systemic chemo. He has already lost sight in his right eye but currently the tumors have stopped growing. However, due to his age and his high risk of reoccurrence, trips to New York will go on for the foreseeable future. The Yerbys discovered Corporate Angel Network through a social media community of parents facing similar diseases. These flights greatly reduce their emotional stress and enable patients to avoid crowded, germ-laden airports and planes.

If you'[d like to do a story about Corporate Angel Network please contact The Yerbys, Peter Fleiss, Executive Director Emeritus of Corporate Angel Network, and Jeff Michael, Director of Aviation of NCR’s Flight Department will be available for interviews at 8:00pm, prior to the 9:22pm flight from Teterboro airport on April 14. (For directions and instructions ? please contact Mona). By commemorating the 50,000th flight, Corporate Angel Network hopes to inform more potential patients and corporations of their important work. Since its inception in 1981, Corporate Angel Network, a 501©(3) organization with Public Charity status, has been matching patients needing to travel for treatment and corporate partners whose jets already travel the desired routes for business. Over 500 well-known corporations participate in Corporate Angel Network’s program, including half of the Fortune 100 and many in the Fortune 500 resulting in more than 225 patient flights every month.

The post Peter Fleiss – Corporate Angel Network’s Executive Director Emeritus appeared first on Good News!.